Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 5
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
Published 10 August 2009 Volume 2009:5 Pages 421—432
DOI https://doi.org/10.2147/NDT.S4101
Review by Single anonymous peer review
Peer reviewer comments 3
Rajasree Nair, Shannon B Moss
Baylor Family Medicine Residency at Garland, Garland, Texas, USA
Abstract: Attention-deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders in young adults and causes significant psychosocial impairment and economic burden to society. Because of the paucity of long-term evidence and lack of national guidelines for diagnosis and management of adult ADHD, most of the data are based on experience derived from management of childhood ADHD. This article reviews the current evidence for the diagnosis and management of adult ADHD with special emphasis on the role of methylphenidate hydrochloride preparations in its treatment. Methylphenidate hydrochloride, a stimulant that acts through the dopaminergic and adrenergic pathways, has shown more than 75% efficacy in controlling the symptoms of adult ADHD. Although concern for diversion of the drug exists, recent data have shown benefits in preventing substance use disorders in patients with adult ADHD.
Keywords: adult ADHD, treatment, stimulants, methylphenidate hydrochloride
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.